NEUTROPENIA, CHEMOTHERAPY-INDUCED FEBRILE

Clinical trials for NEUTROPENIA, CHEMOTHERAPY-INDUCED FEBRILE explained in plain language.

Never miss a new study

Get alerted when new NEUTROPENIA, CHEMOTHERAPY-INDUCED FEBRILE trials appear

Sign up with your email to follow new studies for NEUTROPENIA, CHEMOTHERAPY-INDUCED FEBRILE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New shot aims to shield cancer patients from Chemo's dangerous side effect

Disease control Ongoing

This study is testing a new, longer-lasting injection to prevent a dangerous drop in white blood cells (neutropenia) after chemotherapy. It involves 250 women with breast cancer and compares the new injection to an existing standard treatment. The goal is to see if the new versio…

Matched conditions: NEUTROPENIA, CHEMOTHERAPY-INDUCED FEBRILE

Phase: PHASE3 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

NEUTROPENIA, CHEMOTHERAPY-INDUCED FEBRILE

Get alerted when new NEUTROPENIA, CHEMOTHERAPY-INDUCED FEBRILE trials appear

New shot aims to shield cancer patients from Chemo's dangerous side effect